Analyst consensus rating
Medicus Pharma Analyst Rating: Strong Buy
MDCX is rated Strong Buy by 4 analysts with a $4.48 target. As of 2026-08-20.
Direct answer
Medicus Pharma's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.48.
Forecast evidence checked August 20, 2026.
Get free Medicus Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.27
- Average price target
- $4.48
- High price target
- $9.00
- Low price target
- $0.90
- Low target gap
- +230.6%
- Target upside
- +1,544%
- High target gap
- +3,206.4%
- Target range width
- 2,975.8%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 20, 2026
- Valid through
- August 27, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Medicus Pharma?
Medicus Pharma has a verified Strong Buy consensus. The same dataset has an average price target of $4.48.
How far are Medicus Pharma's low and high targets from the recorded price?
The low target implies +230.6%, while the high target implies +3,206.4%.
How many analysts are included in Medicus Pharma's consensus?
The verified consensus includes 4 analysts.
How is Medicus Pharma's target upside or downside calculated?
The average target of $4.48 is divided by the recorded price of $0.27, then one is subtracted to produce +1,544%. This does not guarantee a future return.
When was Medicus Pharma's analyst forecast verified?
The data was verified on 2026-08-20. The dataset is valid through 2026-08-27.